— Anheuser-Busch InBev (NYSE: BUD) reported earnings of $0.87 per share in the fourth-quarter of 2020 vs. $1.05 per share expected.
— Q4 revenues grew 2.5% to $13.3 billion, vs $13.93 billion expected, as total volume grew 1.6%.
— Company said Coronavirus outbreak has led to a significant decline in demand in China. For the first two months of 2020, the company sees revenue loss of about $285 million and EBITDA loss of around $170 million in China.
— Net CapEx expected to be around $5 billion in FY20
— BUD shares fell 6.8% during pre-market hours.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
